Smell Loss (Anosmia): Post Viral vs Chronic Sinusitis Comparison

Background and Objectives: Smell loss (anosmia/hyposmia) is a common complaint in otorhinolaryngology and may arise from post-viral olfactory dysfunction (PVOD) or chronic rhinosinusitis (CRS). Differentiating these conditions is important because mechanisms, evaluation, and treatment response differ. To compare clinical characteristics, pathophysiology, diagnostic features, and management outcomes of anosmia due to PVOD versus CRS. Methods: A comparative narrative synthesis was performed focusing on onset pattern, nasal symptoms, endoscopic/imaging findings, olfactory testing profiles, and response to medical and procedural interventions. Key domains included inflammatory vs conductive components, duration, prognosis, and evidence-based therapies. Results: PVOD typically presents with sudden smell loss following an upper respiratory infection, often without prominent nasal obstruction. Mechanisms are primarily sensorineural, involving olfactory neuroepithelium injury and inflammatory-mediated dysfunction. Nasal endoscopy and imaging are often normal or minimally inflamed. Recovery is variable, with the greatest improvement usually occurring in the first months; olfactory training is central, while short courses of corticosteroids may be selectively used. In contrast, CRS-related smell loss is commonly gradual or fluctuating, frequently associated with nasal blockage, discharge, facial pressure, and may worsen during exacerbations. It is driven by mucosal inflammation and airflow limitation to the olfactory cleft, with possible neuroepithelial changes in long-standing disease. Endoscopy may reveal mucosal edema, purulence, or polyps, and CT often shows sinus opacification/osteomeatal complex disease. Smell outcomes improve more consistently with intranasal corticosteroids, saline irrigation, and in selected cases systemic steroids and endoscopic sinus surgery, especially in CRS with nasal polyps. Conclusion: PVOD and CRS cause anosmia through distinct dominant mechanisms—sensorineural injury in PVOD versus inflammatory/conductive dysfunction in CRS—leading to different clinical patterns and treatment responses. Careful history, nasal examination, and targeted investigations (endoscopy/CT when indicated) support accurate diagnosis and guide management, with olfactory training emphasized for PVOD and anti-inflammatory plus sinus-directed therapy prioritized for CRS.